Cargando…
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
Neuroblastoma (NB) is the second most common solid pediatric tumor and is characterized by clinical and biological heterogeneity, and stage-IV of the disease represents 50% of all cases. Considering the limited success of present chemotherapy treatment, it has become necessary to find new and effect...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641341/ https://www.ncbi.nlm.nih.gov/pubmed/23579276 http://dx.doi.org/10.1038/cddis.2013.118 |